Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: GLP-1 RA Group in at-risk Adults with type 2 diabetes with moderate CV risk

Raw json | Download

{
  "resourceType" : "Group",
  "id" : "236535",
  "meta" : {
    "versionId" : "77",
    "lastUpdated" : "2026-01-29T20:44:43.900Z",
    "profile" : [
      🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-group"
    ]
  },
  "language" : "en",
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n  <table class=\"narrative-table\">\n    <tbody>\n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\"><a name=\"metadata\"> </a>Metadata</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">GLP-1 RA Group in at-risk Adults with type 2 diabetes with moderate CV risk</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n  \n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Identifier</th>\n\n\n\n<td class=\"content-container\">236535</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Use Context</th>\n\n\n\n<td class=\"content-container\">\n    Evidence Communication\n\n = \n    ExposureGroup\n\n\n</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Steward (Publisher)</th>\n\n\n\n<td class=\"content-container\">Computable Publishing LLC</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Description</th>\n\n\n\n<td class=\"content-container\"><div><p>Glucagon-Like Peptide-1 (GLP-1) receptor agonists</p>\n</div></td>\n\n\n</tr>\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Copyright</th>\n\n\n\n<td class=\"content-container\"><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>\n</div></td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Type</th>\n\n\n\n<td class=\"content-container\">Person</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n  <th colspan=\"2\" scope=\"row\" class=\"row-header\">Generated using version 0.5.6 of the sample-content-ig Liquid templates</th>\n</tr>\n\n    </tbody>\n  </table>\n</div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/artifact-author",
      "valueContactDetail" : {
        "name" : "Computable Publishing®: MAGIC-to-FEvIR Converter"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact",
      "valueRelatedArtifact" : {
        "type" : "part-of",
        "resourceReference" : {
          "type" : "Composition",
          "identifier" : {
            "type" : {
              "text" : "FEvIR Linking Identifier"
            },
            "system" : "https://fevir.net/FLI",
            "value" : "MAGIC-5288-j1Wqrn-conversion-report",
            "assigner" : {
              "display" : "Computable Publishing LLC"
            }
          },
          "display" : "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes"
        }
      }
    },
    {
      "url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as",
      "valueMarkdown" : "GLP-1 RA Group in at-risk Adults with type 2 diabetes with moderate CV risk [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236535. Revised 2026-01-29. Available at: https://fevir.net/resources/Group/236535. Computable resource at: https://fevir.net/resources/Group/236535#json."
    }
  ],
  "url" : "https://fevir.net/resources/Group/236535",
  "identifier" : [
    {
      "type" : {
        "coding" : [
          {
            "system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code" : "ACSN",
            "display" : "Accession ID"
          }
        ],
        "text" : "FEvIR Object Identifier"
      },
      "system" : "https://fevir.net/FOI",
      "value" : "236535",
      "assigner" : {
        "display" : "Computable Publishing LLC"
      }
    },
    {
      "type" : {
        "text" : "FEvIR Linking Identifier"
      },
      "system" : "https://fevir.net/FLI",
      "value" : "MAGIC-5288-j1Wqrn-intervention-group-MAGIC-5288-j1Wqrn-intervention-85390-I-85789",
      "assigner" : {
        "display" : "Computable Publishing LLC"
      }
    }
  ],
  "title" : "GLP-1 RA Group in at-risk Adults with type 2 diabetes with moderate CV risk",
  "status" : "active",
  "publisher" : "Computable Publishing LLC",
  "contact" : [
    {
      "telecom" : [
        {
          "system" : "email",
          "value" : "support@computablepublishing.com"
        }
      ]
    }
  ],
  "description" : "Glucagon-Like Peptide-1 (GLP-1) receptor agonists",
  "useContext" : [
    {
      "code" : {
        "system" : "https://fevir.net/resources/CodeSystem/179423",
        "code" : "evidence-communication",
        "display" : "Evidence Communication"
      },
      "valueCodeableConcept" : {
        "coding" : [
          {
            "system" : "https://fevir.net/resources/CodeSystem/179423",
            "code" : "ExposureGroup",
            "display" : "ExposureGroup"
          }
        ]
      }
    }
  ],
  "copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "type" : "person",
  "membership" : "enumerated",
  "combinationMethod" : "all-of",
  "characteristic" : [
    {
      "code" : {
        "text" : "Member of"
      },
      "valueReference" : {
        🔗 "reference" : "Group/236533",
        "type" : "Group",
        "identifier" : {
          "type" : {
            "text" : "FEvIR Linking Identifier"
          },
          "system" : "https://fevir.net/FLI",
          "value" : "MAGIC-5288-j1Wqrn-population-group-85390-85789",
          "assigner" : {
            "display" : "Computable Publishing LLC"
          }
        },
        "display" : "Adults with type 2 diabetes and established CVD (but no CKD)"
      },
      "exclude" : false,
      "description" : "inclusion in Adults with type 2 diabetes with moderate CV risk"
    },
    {
      "code" : {
        "text" : "Exposed to"
      },
      "valueReference" : {
        🔗 "reference" : "Group/236532",
        "type" : "Group",
        "identifier" : {
          "type" : {
            "text" : "FEvIR Linking Identifier"
          },
          "system" : "https://fevir.net/FLI",
          "value" : "MAGIC-5288-j1Wqrn-intervention-85390-I-85789",
          "assigner" : {
            "display" : "Computable Publishing LLC"
          }
        },
        "display" : "Glucagon-Like Peptide-1 (GLP-1) receptor agonists"
      },
      "exclude" : false,
      "description" : "received GLP-1 RA"
    }
  ]
}